Wei Zhang

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 12

Top Topics

Prognostic Factors

Staphylococcus Aureus

Dendritic Cells

Immune Response

Top Venues

Cancer research communications

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Wang, Xiaobo Cheng, Yanling Jin, Bili Xia, Ran Qin, Wei Zhang, Huiliang Hu, Xiaoting Mao, Liting Zhou, Jia Yan, Xiaoyan Zhang, Jianqing Xu
Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1 + CD8 + T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer. Cancer research communications 3 (6) (2023)
Jing Wang, Xiaobo Cheng, Yanling Jin, Bili Xia, Ran Qin, Wei Zhang, Huiliang Hu, Xiaoting Mao, Liting Zhou, Jia Yan, Xiaoyan Zhang, Jianqing Xu
Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1 + CD8 + T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer. Cancer research communications 3 (6) (2023)
Jing Wang, Xiaobo Cheng, Yanling Jin, Bili Xia, Ran Qin, Wei Zhang, Huiliang Hu, Xiaoting Mao, Liting Zhou, Jia Yan, Xiaoyan Zhang, Jianqing Xu
Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1 + CD8 + T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer. Cancer research communications 3 (6) (2023)
Jing Wang, Xiaobo Cheng, Yanling Jin, Bili Xia, Ran Qin, Wei Zhang, Huiliang Hu, Xiaoting Mao, Liting Zhou, Jia Yan, Xiaoyan Zhang, Jianqing Xu
Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1 + CD8 + T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer. Cancer research communications 3 (6) (2023)
Jing Wang, Xiaobo Cheng, Yanling Jin, Bili Xia, Ran Qin, Wei Zhang, Huiliang Hu, Xiaoting Mao, Liting Zhou, Jia Yan, Xiaoyan Zhang, Jianqing Xu
Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1 + CD8 + T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer. Cancer research communications 3 (6) (2023)
Wei Zhang, Juyoung Hwang, Dhananjay Yadav, Eun-Koung An, Minseok Kwak, Peter Chang-Whan Lee, Jun-O Jin
Enhancement of Immune Checkpoint Inhibitor-Mediated Anti-Cancer Immunity by Intranasal Treatment of Ecklonia cava Fucoidan against Metastatic Lung Cancer. International journal of molecular sciences 22 (17) (2021)
Wei Zhang, Juyoung Hwang, Hae-Bin Park, Seong-Min Lim, Seulgi Go, Jihoe Kim, Inho Choi, Sangguan You, Jun-O Jin
Human Peripheral Blood Dendritic Cell and T Cell Activation by Codium fragile Polysaccharide. Marine drugs 18 (11) (2020)
Yuhua Wang, Wei Zhang, Seong-Min Lim, Li Xu, Jun-O Jin
Interleukin-10-Producing B Cells Help Suppress Ovariectomy-Mediated Osteoporosis. Immune network 20 (6) (2020)
Wei Zhang, Li Xu, Xiaoyan Zhang, Jianqing Xu, Jun-O Jin
CD8α- conventional dendritic cells control Vβ T-cell immunity in response to Staphylococcus aureus infection in mice. Immunology 159 (4) (2020)
Wei Zhang, Li Xu, Hae-Bin Park, Juyoung Hwang, Minseok Kwak, Peter Chang-Whan Lee, Guang Liang, Xiaoyan Zhang, Jianqing Xu, Jun-O Jin
Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy. Nature communications 11 (1) (2020)
Wei Zhang, Takasi Okimura, Tatsuya Oda, Jun-O Jin
Ascophyllan Induces Activation of Natural Killer Cells in Mice In Vivo and In Vitro. Marine drugs 17 (4) (2019)
Wei Zhang, Minseok Kwak, Hae-Bin Park, Takasi Okimura, Tatsuya Oda, Peter Chang-Whan Lee, Jun-O Jin
Activation of Human Dendritic Cells by Ascophyllan Purified from Ascophyllum nodosum. Marine drugs 17 (1) (2019)